Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status

Drug and Alcohol Dependence

Volumn 108, Issue 1-2, 2010, Pages 134-137

  Day, Carolyn A ^a   White, Bethany ^b   Dore, Gregory J ^b   van Beek, Ingrid ^c   Rodgers, Craig ^c   Cunningham, Philip ^d   Wodak, Alex ^e   Maher, Lisa ^b,f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Centre Kings Cross   (Australia)

^d St Vincent's Centre for Applied Medical Research   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Hepatitis B virus; Injecting drug users; Vaccination

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; AUSTRALIA; DRUG ABUSE; HEALTH STATUS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SEROLOGY; VACCINATION; VIRUS IMMUNITY;

ADULT; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; VACCINATION; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 77649181416     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.11.013     Document Type: Article

References (30)

1. Alter M.J. Epidemiology and prevention of hepatitis B. Semin. Liver Dis. 23 (2003) 39-46
2. Amin J., Law M.G., Bartlett M., Kaldor J.M., and Dore G.J. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 368 (2006) 938-945
3. Anderson B., Bodsworth N.J., Rohrsheim R.A., and Donovan B.J. Hepatitis B virus infection and vaccination status of high risk people in Sydney: 1982 and 1991. Med. J. Aust. 161 (1994) 368-371
4. Best D., Noble A., Finch E., Gossop M., Sidwell C., and Strang J. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ 319 (1999) 290-291
5. Black E., Degenhardt L., and Stafford J. NSW Drug Trends 2005: Findings from the Illicit Drug Reporting System (IDRS) (2006), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
6. Campbell J.V., Garfein R.S., Thiede H., Hagan H., Ouellet L.J., Golub E.T., Hudson S.M., Ompad D.C., Weinbaum C., and for the DUIT Study Team. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend. 91 Suppl 1 (2007) S64-S72
7. Crofts N., Hopper J.L., Milner R., Breschkin A.M., Bowden D.S., and Locarnini S.A. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV. Eur. J. Epidemiol. 10 (1994) 687-694
8. Crofts N., Stewart T., Hearne P., Ping X.Y., Breshkin A.M., and Locarnini S.A. Spread of bloodborne viruses among Australian prison entrants. BMJ 310 (1995) 285-288
9. Day C., and Dolan K. Correlates of hepatitis C testing among heroin users in Sydney. Health Promot. J. Austr. 17 (2006) 70-72
10. Day C., White B., Ross J., and Dolan K. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney. Aust. N. Z. J. Public Health 27 (2003) 558
11. Day C.A., White B., Thein H.H., Doab A., Dore G.J., Bates A., Holden J., and Maher L. Experience of HIV and hepatitis C testing among injecting drug users in Sydney, Australia. AIDS Care 20 (2008) 116-123
12. Des Jarlais D.C., Fisher D.G., Newman J.C., Trubatch B.N., Yancovitz M., Paone D., and Perlman D. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program. Am. J. Public Health 91 (2001) 1791-1792
13. Francois G., Hallauer J., and Van Damme P. Hepatitis B vaccination: how to reach risk groups. Vaccine 21 (2002) 1-4
14. Gidding H.F., Warlow M., MacIntyre C.R., Backhouse J., Gilbert G.L., Quinn H.E., and McIntyre P.B. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine 25 (2007) 8637-8641
15. Judd A., Hickman M., Hope V.D., Sutton A.J., Stimson G.V., Ramsay M.E., Gill O.N., and Parry J.V. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?. J. Viral Hepat. 14 (2007) 584-591
16. Kuo I., Mudrick D.W., Strathdee S.A., Thomas D.L., and Sherman S.G. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users. Clin. Infect. Dis. 38 (2004) 587-590
17. MacDonald V., Dore G.J., Amin J., and Van Beek I. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary sexual health care facility. Sex. Health 4 (2007) 27-30
18. Maher L., Jalaludin B., Chant K.G., Jayasuriya R., Sladden T., Kaldor J.M., and Sargent P.L. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 101 (2006) 1499-1508
19. Maher L., Li J., Jalaludin B., Chant K.G., and Kaldor J.M. High hepatitis C incidence in new injecting drug users: a policy failure?. Aust. N. Z. J. Public Health 31 (2007) 30-35
20. National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey: National Data Report 2000-2004 (2005), National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney
21. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report 2006 (2006), National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney
22. National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey: National Data Report 2002-2006 (2007), NCHECR, University of New South Wales, Sydney
23. Raimondo G., Brunetto M.R., Pontisso P., Smedile A., Maina A.M., Saitta C., Squadrito G., Tono N., and Associazione Italiana Studio Fegato Cooperative Group. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 43 (2006) 100-107
24. Seal K.H., Kral A.H., Lorvick J., McNees A., Gee L., and Edlin B.R. A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug Alcohol Depend. 71 (2003) 127-131
25. Sutton A.J., Gay N.J., Edmunds W.J., Hope V.D., Gill O.N., and Hickman M. Modelling the force of infection for hepatitis and hepatitis C in injecting drug users in England and Wales. BMC Infect. Dis. 6 (2006) 93
26. Sindelar J.L., Olmstead T.A., and Peirce J.M. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 102 (2007) 1463-1471
27. Wedemeyer H., Cornberg M., Tegtmeyer B., Frank H., Tillmann H.L., and Manns M.P. Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication. Clin. Microbiol. Infect. 10 (2004) 70-72
28. White B., Day C., Degenhardt L., Kinner S., Fry C., Bruno R., and Johnston J. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia. Drug Alcohol Depend. 83 (2006) 210-217
29. White B., Day C.A., Thein H.-H., Doab A., Bates A., Holden J., and Maher L. Acceptability of hepatitis C virus testing methods among injecting drug users. Drug Alcohol Rev. 31 (2008) 1-5
30. Winstock A.R., Anderson C.M., and Sheridan J. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia. Med. J. Aust. 184 (2006) 560-562